Zimmer Biomet Holdings (ZBH) Revenue — Quarter Ended Dec 31, 2024
Revenue for the quarter increased compared to the prior quarter and rose relative to the same quarter a year earlier. The annual report filing included standard forward-looking cautionary language and liquidity disclosures.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the quarter increased compared to the prior quarter and rose relative to the same quarter a year earlier. The annual report filing included standard forward-looking cautionary language and liquidity disclosures.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2B
Revenue reported for this quarter.
Quarter-over-quarter
+10.9%
Change from the immediately preceding quarter.
Year-over-year
+4.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$7.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $1.9B | +3.2% |
| Jun 30, 2024 | $1.9B | +3.9% |
| Sep 30, 2024 | $1.8B | +4.0% |
| Dec 31, 2024 | $2B | +4.3% |
Revenue performance
The reported revenue was higher than in the immediately preceding quarter. The company’s filing noted available borrowing capacity and cash flows from operations to meet liquidity needs, though no direct causation was tied to revenue.
Quarterly comparison
Revenue in this quarter was above both the preceding quarter and the same quarter one year ago. The sequential improvement followed a pattern of quarterly increases across the preceding periods.
What to watch
Monitor whether the sequential revenue growth rate persists in the next reporting period.